Q1 2014's Top Pharma & Biotech M&A Deals

Pharma IQ

The global pharmaceuticals industry has witnessed significant change in the last few years from patent expiry to declining product pipelines. In addition the cost of developing and marketing a new drug continues to soar. One way pharmaceutical and biotech companies are dealing with these challenges is by turning to mergers and acquisitions as a way to improve pipelines, efficiency and enter new markets. A recent KPMG 2014 M&A Survey Report predicts healthcare, pharmaceuticals and life scienc...
To continue reading this story get free access